Table VI.
Cox values of variables in relation to survival at 3 and 6 months following surgery.
| Variables | P-value | Hazard risk | 95% CI |
|---|---|---|---|
| 3 months | |||
| Univariate | |||
| STK1p (<2.0 vs. ≥2.0 pM) | 0.080 | - | - |
| Stage (I/II vs. III/IV) | 0.028 | 11.071 | 1.29–94.92 |
| Size (<5.0 vs. ≥5.0 cm) | 0.028 | 11.071 | 1.29–94.92 |
| Age (<50 vs. ≥51 years) | 0.891 | - | - |
| Multivariate | |||
| STK1p (<2.0 vs. ≥2.0 pM) | 0.028 | 11.071 | 1.29–94.92 |
| Stage (I/II vs. III/IV) | 0.493 | - | - |
| Size (<5.0 vs. ≥5.0 cm) | 0.540 | - | - |
| Age (<50 vs. ≥51 years) | 0.940 | - | - |
| 6 months | |||
| Univariate | |||
| STK1p (<2.0 vs. ≥2.0 pM) | 0.021 | 12.67 | 1.48–108.79 |
| Stage (I/II vs. III/IV) | 0.028 | 11.07 | 1.29–94.92 |
| Size (<5.0 vs. ≥5.0 cm) | 0.028 | 11.07 | 1.29–94.92 |
| Age (<50 vs. ≥51 years) | 0.891 | - | - |
| Multivariate | |||
| STK1p (<2.0 vs. ≥2.0 pM) | 0.010 | 12.67 | 1.65–40.87 |
| Stage (I/II vs. III/IV) | 0.497 | - | - |
| Size (<5.0 vs. ≥5.0 cm) | 0.122 | - | - |
| Age (<50 vs. ≥51 years) | 0.122 | - | - |
CI, confidence interval; STK1p, serum thymidine kinase 1 protein.